North America Analgesics Market Size, Share & Industry Trends Analysis Report By Type (Non-opioids and Opioids), By Route of Administration (Oral, Transdermal, Intravenous, Topical, and Rectal), By Country and Growth Forecast, 2022 – 2028
Description
North America Analgesics Market Size, Share & Industry Trends Analysis Report By Type (Non-opioids and Opioids), By Route of Administration (Oral, Transdermal, Intravenous, Topical, and Rectal), By Country and Growth Forecast, 2022 – 2028
The North America Analgesics Market would witness market growth of 6.1% CAGR during the forecast period (2022-2028).
Migraine is a condition that is more than just a headache. Nausea, dizziness, and eye issues are common side effects of this illness. The etiology is unknown. However, some specialists believe it is a central nervous system hereditary condition linked to epilepsy. Triptans, which function on serotonin receptors, and nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed by doctors. Preventive measures, like dietary adjustments, blood pressure medication, or anti-seizure medicines, may be required if migraines occur frequently. Analgesics can help to relieve migraine discomfort. Analgesics are necessary drugs for some people. Patients with acute serious pain, cancer pain, or pain at the end of life benefit from analgesics because they improve their quality of life. These factors would propel the growth of the analgesics market in the coming years.
Because of the rising prevalence of chronic diseases and the widespread utilization of analgesics as a pain reliever as well as for illicit purposes, the demand for analgesics is increasing in the United States. In order to meet the updated regulatory standards, the US is increasing its efforts on labeled opioid producers attempting to sell new drugs. Furthermore, because of government support for ongoing clinical research, the United States has a robust pain management sector. In addition, the significant prevalence of various major market players across the region is another factor aiding in the introduction of several new innovations across this sector. Pfizer, Purdue Pharmaceuticals, Janssen Pharmaceuticals, Assertio Therapeutics, as well as other North American companies have helped the country achieve its excellent accomplishments. Due to the development of new formulations and abuse deterrence studies, Purdue was the first company to offer opioids with abuse-deterrent properties.
The US market dominated the North America Analgesics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $11,043 Million by 2028. The Canada market is anticipated to grow at a CAGR of 8.5% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 7.5% during (2022 - 2028).
Based on Type, the market is segmented into Non-opioids and Opioids. Based on Route of Administration, the market is segmented into Oral, Transdermal, Intravenous, Topical, and Rectal. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Reckitt Benckiser Group PLC, Abbott Laboratories, Johnson & Johnson, Bayer AG, Endo International PLC, GlaxoSmithKline PLC, Pfizer, Inc., Sanofi S.A., and Eli Lilly And Company.
Scope of the Study
Market Segments covered in the Report:
By Type
The North America Analgesics Market would witness market growth of 6.1% CAGR during the forecast period (2022-2028).
Migraine is a condition that is more than just a headache. Nausea, dizziness, and eye issues are common side effects of this illness. The etiology is unknown. However, some specialists believe it is a central nervous system hereditary condition linked to epilepsy. Triptans, which function on serotonin receptors, and nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly prescribed by doctors. Preventive measures, like dietary adjustments, blood pressure medication, or anti-seizure medicines, may be required if migraines occur frequently. Analgesics can help to relieve migraine discomfort. Analgesics are necessary drugs for some people. Patients with acute serious pain, cancer pain, or pain at the end of life benefit from analgesics because they improve their quality of life. These factors would propel the growth of the analgesics market in the coming years.
Because of the rising prevalence of chronic diseases and the widespread utilization of analgesics as a pain reliever as well as for illicit purposes, the demand for analgesics is increasing in the United States. In order to meet the updated regulatory standards, the US is increasing its efforts on labeled opioid producers attempting to sell new drugs. Furthermore, because of government support for ongoing clinical research, the United States has a robust pain management sector. In addition, the significant prevalence of various major market players across the region is another factor aiding in the introduction of several new innovations across this sector. Pfizer, Purdue Pharmaceuticals, Janssen Pharmaceuticals, Assertio Therapeutics, as well as other North American companies have helped the country achieve its excellent accomplishments. Due to the development of new formulations and abuse deterrence studies, Purdue was the first company to offer opioids with abuse-deterrent properties.
The US market dominated the North America Analgesics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $11,043 Million by 2028. The Canada market is anticipated to grow at a CAGR of 8.5% during (2022 - 2028). Additionally, The Mexico market would exhibit a CAGR of 7.5% during (2022 - 2028).
Based on Type, the market is segmented into Non-opioids and Opioids. Based on Route of Administration, the market is segmented into Oral, Transdermal, Intravenous, Topical, and Rectal. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Reckitt Benckiser Group PLC, Abbott Laboratories, Johnson & Johnson, Bayer AG, Endo International PLC, GlaxoSmithKline PLC, Pfizer, Inc., Sanofi S.A., and Eli Lilly And Company.
Scope of the Study
Market Segments covered in the Report:
By Type
- Non-opioids
- Opioids
- Oral
- Transdermal
- Intravenous
- Topical
- Rectal
- US
- Canada
- Mexico
- Rest of North America
- AbbVie, Inc.
- Reckitt Benckiser Group PLC
- Abbott Laboratories
- Johnson & Johnson
- Bayer AG
- Endo International PLC
- GlaxoSmithKline PLC
- Pfizer, Inc.
- Sanofi S.A.
- Eli Lilly And Company
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
74 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Analgesics Market, by Type
- 1.4.2 North America Analgesics Market, by Route of Administration
- 1.4.3 North America Analgesics Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
- Chapter 3. Strategies deployed in Analgesics Market
- Chapter 4. North America Analgesics Market by Type
- 4.1 North America Macro processing Market by Country
- 4.2 North America Micro processing Market by Country
- Chapter 5. North America Analgesics Market by Route of Administration
- 5.1 North America Oral Market by Country
- 5.2 North America Transdermal Market by Country
- 5.3 North America Intravenous Market by Country
- 5.4 North America Topical Market by Country
- 5.5 North America Rectal Market by Country
- Chapter 6. North America Analgesics Market by Country
- 6.1 US Analgesics Market
- 6.1.1 US Analgesics Market by Type
- 6.1.2 US Analgesics Market by Route of Administration
- 6.2 Canada Analgesics Market
- 6.2.1 Canada Analgesics Market by Type
- 6.2.2 Canada Analgesics Market by Route of Administration
- 6.3 Mexico Analgesics Market
- 6.3.1 Mexico Analgesics Market by Type
- 6.3.2 Mexico Analgesics Market by Route of Administration
- 6.4 Rest of North America Analgesics Market
- 6.4.1 Rest of North America Analgesics Market by Type
- 6.4.2 Rest of North America Analgesics Market by Route of Administration
- Chapter 7. Company Profiles
- 7.1 AbbVie, Inc. (Allergan PLC)
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 Recent strategies and developments:
- 7.1.5.1 Approvals and Trials:
- 7.2 Reckitt Benckiser Group PLC
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expenses
- 7.2.5 Recent strategies and developments:
- 7.2.5.1 Product Launches and Product Expansions:
- 7.3 Abbott Laboratories
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expense
- 7.3.5 Recent strategies and developments:
- 7.3.5.1 Product Launches and Product Expansions:
- 7.3.5.2 Approvals and Trials:
- 7.4 Johnson & Johnson
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Segmental &Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.5 Bayer AG
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
- 7.5.5 Recent strategies and developments:
- 7.5.5.1 Product Launches and Product Expansions:
- 7.6 Endo International PLC
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.6.4 Research & Development Expense
- 7.7 GlaxoSmithKline PLC
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expense
- 7.7.5 Recent strategies and developments:
- 7.7.5.1 Partnerships, Collaborations, and Agreements:
- 7.7.5.2 Geographical Expansions:
- 7.8 Pfizer, Inc.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional & Segmental Analysis
- 7.8.4 Research & Development Expense
- 7.8.5 Recent strategies and developments:
- 7.8.5.1 Partnerships, Collaborations, and Agreements:
- 7.9 Sanofi S.A.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expense
- 7.10. Eli Lilly And Company
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Regional Analysis
- 7.10.4 Research & Development Expenses
- 7.10.5 Recent strategies and developments:
- 7.10.5.1 Partnerships, Collaborations, and Agreements:
- 7.10.5.2 Geographical Expansions:
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
